←Back to Expert Scholars
Translational Medicine / 转化医学CLL, Fixed-Duration Therapy
Arnon Kater
MD, PhD
🏢Amsterdam UMC🌐Netherlands
Professor of Hematology
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Arnon Kater has led European CLL trials including HOVON studies of venetoclax-based fixed-duration combinations. His work contributed long-term data from MURANO and related studies supporting treatment-free intervals. He continues to investigate minimal residual disease-guided retreatment strategies.
Share:
🧪Research Fields 研究领域
CLL
venetoclax
MURANO
fixed-duration therapy
European trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Arnon Kater 的研究动态
Follow Arnon Kater's research updates
留下邮箱，当我们发布与 Arnon Kater（Amsterdam UMC）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment